{"instance_id": "ws_en_019", "response": "```markdown\n| Company Name         | Listing Board | Bloomberg ticker | Listing Date      | Initial Offering Price(per share) | Total Funds Raised in 2024(million) | Revenue in 2024(million) | Net Income Attributable to Shareholders(million) | R&D Expenses(million) |\n|----------------------|---------------|------------------|-------------------|----------------------------------|-------------------------------------|-------------------------|------------------------------------------------|----------------------|\n| CG Oncology          | NASDAQ        | CGON             | 2024-12-16        | 15.00                            | 82.4                               | N/A                     | N/A                                            | 82.1                 |\n| Zenas BioPharma      | NASDAQ        | ZBIO             | 2024-02-09        | 17.00                            | 258.7                              | 10.4                    | N/A                                            | 10.4                 |\n| Upstream Bio         | NASDAQ        | UPB              | 2024-10-11        | 15.00                            | 255.0                              | 31.4                    | N/A                                            | 33.0                 |\n| MBX Biosciences      | NASDAQ        | MBX              | 2024-02-09        | 15.00                            | 225.0                              | 28.9                    | N/A                                            | 28.9                 |\n| Metagenomi           | NASDAQ        | MGX              | 2024-02-09        | 15.00                            | 225.0                              | 26.3                    | -94.8                                          | 109.2                |\n```"}
